Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 319

Sort by

Sort Order Select

Journal Articles

Sonrotoclax (BGB-11417) monotherapy in patients with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) previously treated with a bruton tyrosine kinase (BTK) inhibitor: Early results from A phase 1/2 study

Michael Wang, Yuqin Song, Olivier Hermine, Yuerong Shuang, Wojciech Jurczak, João Samuel de Holanda Farias, Carolina Mahuad, Muhit Ozcan, Ron D. Jachimowicz, Tianlei Chen, Elena Ivanova, Xiaotong Li, Gabriel Man, Priscille Bourquelot, Remus Vezan, Toby Eyre

Blood (2025) 146 (Supplement 1): 663.

https://doi.org/10.1182/blood-2025-663

Published: 2025

Journal Articles

Anti-CD19 CAR-T cells for Mantle Cell Lymphoma with central nervous system involvement: A study of the french descart registry.

Stephanie Guidez, Marie-Thérèse Rubio, Roberta Di Blasi, Gabriel Brisou, Morgane Cheminant, Emmanuel Bachy, Franck Morschhauser, Cristina Castilla-Llorente, Blandine Guffroy, Roch Houot, Steven Le Gouill, Olivier Hermine, Fabien Le Bras, Laure Ricard, Damien Roos Weil

Blood (2025) 146 (Supplement 1): 3598.

https://doi.org/10.1182/blood-2025-3598

Published: 2025

Journal Articles

Availability of blood products and transfusion practices in sub-saharan Africa for the management of patients with sickle cell disease: A survey in 16 countries.

Geoffrey Cheminet, Saliou Diop, Françoise Bernaudin, Indou Deme-Ly, Binta Coulibaly, Anne Corbasson, Ibrahima Diagne, Charlotte Eposse Ekoube, Frederic Galacteros, Olivier Hermine, Eléonore Kafando, Mariane de Montalembert, Constant Vodouhé, Ahoefa Vovor, Brigitte Ranque, Leon Tshilolo, France Pirenne, Dapa Diallo, Jean-Benoit Arlet

Blood (2025) 146 (Supplement 1): 2966.

https://doi.org/10.1182/blood-2025-2966

Published: 2025

Journal Articles

Single-cell metabolic profiling of post-infusion CD22 and CD19/CD22 CAR T-cells reveals a shift toward amino acid–driven oxphos informing SLC-armored CAR design

Blood (2025) 146 (Supplement 1): 502.

https://doi.org/10.1182/blood-2025-502

Published: 2025

Journal Articles

CAR T-cell therapy in secondary CNS lymphomas: A real-world study from the descar-t registry

Blood (2025) 146 (Supplement 1): 1012.

https://doi.org/10.1182/blood-2025-1012

Published: 2025

Journal Articles

Outcome of patients with large B-cell lymphoma relapsing after second-line CAR-t: Insights from the descar-t registry

Blood (2025) 146 (Supplement 1): 956.

https://doi.org/10.1182/blood-2025-956

Published: 2025

Journal Articles

Inflammatory Waldenström macroglobulinemia is associated with monocyte dysregulation and IL-1β production

Blood (2025) 146 (Supplement 1): 1777.

https://doi.org/10.1182/blood-2025-1777

Published: 2025

Journal Articles

Integrated clinico-biological profiling identifies a high-risk epigenetic signature in Mantle Cell Lymphoma: A lysa study

Blood (2025) 146 (Supplement 1): 661.

https://doi.org/10.1182/blood-2025-661

Published: 2025

Journal Articles

HLH-JAK, the first OPEN-label, phase II study evaluating ANTI-JAK1 itacitinib, for NON severe HLH in adults.

Coralie Bloch, Marouane Boubaya, Estibaliz Lazarro, Louis Terriou, Marc Michel, Julien Carvelli, Olivier Hermine

Blood (2025) 146 (Supplement 1): 190.

https://doi.org/10.1182/blood-2025-190

Published: 2025

Journal Articles

Comparison of axicabtagene ciloleucel to standard regimens as second line treatment for large B cell lymphoma in real life: A lysa study from descar-T and realysa registries

Gabriel Brisou, Aurelien Belot, Emmanuel Bachy, Herve Ghesquieres, François-Xavier Gros, Krimo Bouabdallah, Guillaume Cartron, Roberta Di Blasi, Roch Houot, Cedric Rossi, Amandine Durand, Fabien Le Bras, Corinne Haioun, Thomas Gastinne, Remy Dulery, Pierre Bories, Fabrice Jardin, Blandine Guffroy, Luc-Matthieu Fornecker, Cristina Castilla-Llorente, Gandhi Damaj, Franck Morschhauser, Michael Loschi, Stephanie Guidez, Choquet Sylvain, Aline Schmidt, Laurianne Drieu La Rochelle, Marie-Thérèse Rubio, Sylvain Carras, Jacques-Olivier Bay, Adrien Chauchet, Magalie Joris, Ludovic Fouillet, Laure Lebras, Julie Abraham, Fontanet Bijou, Olivier Hermine, Antoine Bonnet, Justine Decroocq, Sandy Amorim, Nadine Morineau, Pauline Lionne, Sophie Dennetiere, Laura Herbreteau, Bernard Drenou, Launay Vincent, Gaelle Olivier, Gaëlle Labouré, Olivier Fitoussi, Christophe Fruchart, Cecile Leyronnas, Fanny Cherblanc, Elodie Gat, Benoit Tessoulin

Blood (2025) 146 (Supplement 1): 2764.

https://doi.org/10.1182/blood-2025-2764

Published: 2025

Journal Articles

Impact of the number of bridging therapy lines on outcomes after axi-cel in LBCL: A lysa study from the descar-T registry

Blood (2025) 146 (Supplement 1): 2745.

https://doi.org/10.1182/blood-2025-2745

Published: 2025

Journal Articles

Comparison of axi-cel versus liso-cel as 2nd line therapy for relapsed/refractory large B-cell lymphoma in real-life: A lysa study from the descar-T registry

Blood (2025) 146 (Supplement 1): 127.

https://doi.org/10.1182/blood-2025-127

Published: 2025

Journal Articles

Association between inflammatory and hemolysis markers in children with sickle cell disease

Capucine Collet, Alma Al Sibaaie, Rachel Rignault-Bricard, Mariane de Montalembert, Joséphine Brice, Melissa Taylor, Martina Bevacqua, Olivier Hermine, Thiago Trovati Maciel, Slimane Allali

Blood (2025) 146 (Supplement 1): 6492.

https://doi.org/10.1182/blood-2025-6492

Published: 2025

Journal Articles

Improved overall survival in patients with advanced systemic mastocytosis treated with avapritinib versus real-world therapy based on mutation-adjusted risk score (MARS) stratification

Blood (2025) 146 (Supplement 1): 5595.

https://doi.org/10.1182/blood-2025-5595

Published: 2025

Journal Articles

Final results of a first-in-human Phase I study of INA03, a novel CD71/TfR1-targeted antibody-drug conjugate, in patients with relapsed or refractory acute leukemia.

Sylvain Garciaz, Pierre Bories, Jean-Marie Boher, Léonor Lopez Almeida, Marie-Anne Hospital, Christian Recher, Colombe Saillard, Yosr Hicheri, Coralie Belanger, Emmanuel Gomez, Renato Monteiro, Pierre Launay, Olivier Hermine, Norbert Vey

Blood (2025) 146 (Supplement 1): 5203.

https://doi.org/10.1182/blood-2025-5203

Published: 2025

Journal Articles

VEXAS anemia is a mosaic erythroblastopenia

Blood blood.2025029081.

https://doi.org/10.1182/blood.2025029081

Published: 2025

Includes: Supplemental data

Journal Articles

Inflammatory Waldenström macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort

Blood (2025) 145 (4): 450–454.

https://doi.org/10.1182/blood.2024025738

Published: 2025

Includes: Supplemental data

Journal Articles

Rap-536, a Murine Luspatercept Analog Ameliorates Anemia and Vaso-Occlusion in Experimental Model of Sickle Cell Disease

Thiago Trovati Maciel, Haoua M Bazoum, Rachel Rignault-Bricard, Shikha Saini, Isabelle Chevalme, Sara El Hoss, Robert Li, Slimane Allali, Rajasekhar N.V.S. Suragani, Olivier Hermine

Blood (2024) 144 (Supplement 1): 621.

https://doi.org/10.1182/blood-2024-201454

Published: 2024

Journal Articles

Real-World Practice Patterns of Patient Management in the Peri-CAR T-Cell Therapy Setting for Patients with Mantle Cell Lymphoma: An International Survey on Behalf of the EBMT Lymphoma Working Party

Gloria Iacoboni, Pere Barba, Irma Khvedelidze, Maud Ngoya, Paolo Corradini, Pierre Sesques, Marion Subklewe, Maria Gomes Da Silva, Gilles Crochet, Jarosław Dybko, Izaskun Zeberio, Alejandro Martín García-Sancho, Tom van Meerten, Maeve O'Reilly, Bertram Glass, Ana Maria Sureda Balari, Peter Dreger, Olivier Hermine, Ali Bazarbachi

Blood (2024) 144 (Supplement 1): 3656.

https://doi.org/10.1182/blood-2024-205389

Published: 2024

Journal Articles

Complement Activation and Its Implication in the Pathophysiology of Hemolytic Anemia and Aging in Mouse Models of Sickle Cell Disease and Beta-Thalassemia

Thiago Trovati Maciel, Nabiha Sbeih, Rachel Rignault-Bricard, Isabelle Chevalme, Slimane Allali, Camille Brochier, Anna Kiialainen, Tovo David, Olivier Hermine

Blood (2024) 144 (Supplement 1): 3870.

https://doi.org/10.1182/blood-2024-207298

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Sonrotoclax (BGB-11417) monotherapy in patients with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) previously treated with a bruton tyrosine kinase (BTK) inhibitor: Early results from A phase 1/2 study

Anti-CD19 CAR-T cells for Mantle Cell Lymphoma with central nervous system involvement: A study of the french descart registry.

Availability of blood products and transfusion practices in sub-saharan Africa for the management of patients with sickle cell disease: A survey in 16 countries.

Single-cell metabolic profiling of post-infusion CD22 and CD19/CD22 CAR T-cells reveals a shift toward amino acid–driven oxphos informing SLC-armored CAR design

CAR T-cell therapy in secondary CNS lymphomas: A real-world study from the descar-t registry

Outcome of patients with large B-cell lymphoma relapsing after second-line CAR-t: Insights from the descar-t registry

Inflammatory Waldenström macroglobulinemia is associated with monocyte dysregulation and IL-1β production

Integrated clinico-biological profiling identifies a high-risk epigenetic signature in Mantle Cell Lymphoma: A lysa study

HLH-JAK, the first OPEN-label, phase II study evaluating ANTI-JAK1 itacitinib, for NON severe HLH in adults.

Comparison of axicabtagene ciloleucel to standard regimens as second line treatment for large B cell lymphoma in real life: A lysa study from descar-T and realysa registries

Impact of the number of bridging therapy lines on outcomes after axi-cel in LBCL: A lysa study from the descar-T registry

Comparison of axi-cel versus liso-cel as 2nd line therapy for relapsed/refractory large B-cell lymphoma in real-life: A lysa study from the descar-T registry

Association between inflammatory and hemolysis markers in children with sickle cell disease

Improved overall survival in patients with advanced systemic mastocytosis treated with avapritinib versus real-world therapy based on mutation-adjusted risk score (MARS) stratification

Final results of a first-in-human Phase I study of INA03, a novel CD71/TfR1-targeted antibody-drug conjugate, in patients with relapsed or refractory acute leukemia.

VEXAS anemia is a mosaic erythroblastopenia

Inflammatory Waldenström macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort

Rap-536, a Murine Luspatercept Analog Ameliorates Anemia and Vaso-Occlusion in Experimental Model of Sickle Cell Disease

Real-World Practice Patterns of Patient Management in the Peri-CAR T-Cell Therapy Setting for Patients with Mantle Cell Lymphoma: An International Survey on Behalf of the EBMT Lymphoma Working Party

Complement Activation and Its Implication in the Pathophysiology of Hemolytic Anemia and Aging in Mouse Models of Sickle Cell Disease and Beta-Thalassemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only